Ocean Biomedical, Inc. (OCEA)

OTCMKTS · Delayed Price · Currency is USD
0.0003
-0.0005 (-62.50%)
Feb 27, 2026, 4:00 PM EST
-99.70%
Market Cap 69.71K
Revenue (ttm) n/a
Net Income (ttm) -30.72M
Shares Out 232.37M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,780
Average Volume 66,260
Open 0.0005
Previous Close 0.0008
Day's Range 0.0003 - 0.0007
52-Week Range n/a
Beta 1.49
RSI 40.39
Earnings Date Apr 2, 2026

About Ocean Biomedical

Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company’s oncology product candidates include OCX-253 anti-Chi3l1 Single-target mAb and OCX-410 anti-Chi3l1/PD-1 Bi-specific antibody for the treatment of non-small cell lung cancer; and OCX-909 anti-Chi3l1/CTLA-4 Bi-specific antibody to treat glioblastoma multiforme. Its fibrosis product candidates consist of OCF-203 anti-Chit1 small molecule for the treatment o... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2019
Employees 7
Stock Exchange OTCMKTS
Ticker Symbol OCEA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.